PMI on track to submit PMTA to market its new Iqos vapour device in the US

Philip Morris International (PMI) has announced that it is continuing preparations to submit a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) in the second half of next year for a new Iqos e-vapour device.

The manufacturer said during its third-quarter earnings presentation that the product was making “good progress” in the markets where it has been launched so far.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ PMI on track to submit PMTA to market its new Iqos vapour device in the US ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ PMI on track to submit PMTA to market its new Iqos vapour device in the US ”






      Philip Morris International (PMI) has announced that it is continuing preparations to submit a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) in the second half of next year for a new Iqos e-vapour device.

      The manufacturer said during its third-quarter earnings presentation that the product was making “good progress” in the markets where it has been launched so far.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik